Skip to main content
SpringerLink
Log in

Linezolid-related AEs in patients with rifampicin-resistant TB

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cui D, et al. Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study Journal of Chemotherapy : 1-7, et al. Nov 2022. Available from: URL: http://doi.org/10.1080/1120009X.2022.2136447

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Linezolid-related AEs in patients with rifampicin-resistant TB. Reactions Weekly 1932, 11 (2022). https://doi.org/10.1007/s40278-022-27376-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-27376-1

Search

Navigation